Sartorius Stedim Biotech SA Financials

Market Capitalization €19.95 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	97.20
Forward PE	47.59
Price to Sales TTM	€6.98
Price to Book MRQ	€5.02
Enterprise to Revenue	7.69
Enterprise to EBITDA	32.94

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	7.15%
Operating Margin	18.98%
Return on Assets TTM	3.19%
Return on Equity TTM	5.25%

Income Statement

Revenue TTM	€2,857,700,096
Revenue per Share TTM	€29.53
Quarterly Revenue Growth	11.70%
Gross Profit TTM	€1,254,300,032
EBITDA	€730,400,000
Net Income to Common TTM	€204,300,000
Diluted EPS TTM	€2.11
Quarterly Earnings Growth YoY	52.60%

Balance Sheet

Total Cash MRQ	€707,600,000
Total Cash per Share MRQ	€7.27
Total Debt MRQ	€
Total Debt to Equity MRQ	73.17
Current Ratio MRQ	1.85
Book Value per Share MRQ	€40.84

Cash Flow

Operating Cash Flow TTM	€879,500,032
Levered Free Cash Flow TTM	€497,324,992

DIM Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	97,299,822
Float Shares	27,731,482
Avg 10 Volume	69,626
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	71.47%
% Held by Institutions	10.72%

Stock Price Summary

Beta	0.93
Fifty Two Week Low	€143.20
Fifty Two Week High	€239.80
Fifty Two Week Change	22.12%
Day 50 MA	€199.69
Day 200 MA	€192.81

Dividends and Splits

Forward Annual Dividend Rate	€0.69
Forward Annual Dividend Yield	0.34%
Trailing Annual Dividend Rate	€0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	32.70%
Dividend Date
Ex Dividend Date	2025-04-02
Last Split Factor
Last Split Date	2016-05-06